Apr 4, 2025 8:00am EDT OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
Mar 17, 2025 8:00am EDT OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders